Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

12 Results

Guidelines and Advice

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2015

Status: Current
ID: PET 2015-1

Oct 2015

Guidelines and Advice

Plerixafor for Autologous Hematopoietic Stem Cell Mobilization and Transplantation for Patients in Ontario

Status: Current
ID: SCT-7

Sep 2015

Guidelines and Advice

Rituximab in Lymphoma and Chronic Lymphocytic Leukemia: A Clinical Practice Guideline

Status: Archived
ID: 6-8
Version: 3

Mar 2015

Guidelines and Advice

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July to December 2014

Status: Current
ID: PET 2014-2

Jun 2015

Guidelines and Advice

PET Imaging in Lymphoma

Status: Current
ID: PET 12

Mar 2015

Guidelines and Advice

Radiopharmaceuticals in the Palliation of Painful Bone Metastases

Status: Archived
ID: 14-1

Jan 2015

Guidelines and Advice

Recommendation Report: Entry and Transfer of Care Criteria for Lung Diagnostic Assessment Programs (DAPs) in Ontario

Status: Education and Information
ID: GL-C50-23-V1
Version: 2

Dec 2015

Drug Safety & Advice

Reference List for Appendix 2 - Extravasation Potential of Various Chemotherapy/Supportive Agents

Jul 2015

Cancer facts

Prevalence - a Different Perspective on Cancer Burden in Ontario

May 2015

Guidelines and Advice

Recommended Criteria of a Pre-printed Order (PPO): Oral Chemotherapy Take-home Prescriptions

Status: Current
ID: GL-C50-21

Jul 2015

Guidelines and Advice

Person-Centred Care Guideline

Status: Current
ID: GL-C50-20

May 2015

Statistical Reports

Prevention System Quality Index 2015

Sep 2015